Cited by 339Cancer, Hypoxia, and MetabolismAngiogenesis and VEGF in CancerMechanisms of cancer metastasis

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Hypoxia-Inducible Factor-1α Is a Key Regulator of Metastasis in a Transgenic Model of Cancer Initiation and Progression

Liao, Debbie, Corle, Courtney, Seagroves, Tiffany N., Johnson, Randall S.·2007·Cancer Research

Open this paper in CoChat — free account

Abstract

Adaptation to hypoxia is a critical step in tumor progression and is, in part, regulated by the transcription factor hypoxia-inducible factor-1α (HIF-1α). Xenograft models have been extensively used to characterize the role of HIF-1α in experimental cancers. Although these models provide an understanding of tumor growth at terminal stages of malignancy, they do not address tumor initiation or metastatic progression. To elucidate these roles, HIF-1α was conditionally deleted in the mammary epithelium of a transgenic mouse model for metastatic breast cancer. Conditional deletion of HIF-1α in the mammary epithelium resulted in delayed tumor onset and retarded tumor growth; this was correlated with decreased tumor cell proliferation. Tumors with conditional deletion of HIF-1α were also less vascular during early tumor progression. Perhaps most surprisingly, deletion of HIF-1α in the mammary epithelium resulted in decreased pulmonary metastasis. These results show that whereas HIF-1α is not required for the initiation of breast tumor growth or tumor cell metastasis, the transcriptional activity of HIF-1α is a significant positive regulator of tumor progression and metastatic potential. [Cancer Res 2007;67(2):563–72]

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-06-2701

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
Retracted
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
Untitled work
(1999) · PubMed · Cited by 2,204
HIF-1α is essential for myeloid cell-mediated inflammation
Cramer, T., Yamanishi, Y., Clausen, B. E., Förster, I., Pawlinski, R., Mackman, N., Haase, V. H., Jaenisch, R., Corr, M., Nizet, V., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00154-5 · Cited by 2,046
Self-citation
VEGF as a Key Mediator of Angiogenesis in Cancer
Carmeliet, P. (2005) · Oncology · doi:10.1159/000088478 · Cited by 1,834
Openings Between Defective Endothelial Cells Explain Tumor Vessel Leakiness
Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., Jain, R. K., & McDonald, D. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65006-7 · Cited by 1,689
HIF‐1α is required for solid tumor formation and embryonic vascularization
Ryan, H. E., Lo, J., & Johnson, R. S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3005 · Cited by 1,579
Self-citation

Show all 38 references

Sorted by citations

Items 201–300 of 339

HIF-1α modulation by topoisomerase inhibitors in non-small cell lung cancer cell lines
Choi, Y. J., Rho, J. K., Lee, S. J., Jang, W. S., Lee, S. S., Kim, C. H., & Lee, J. C. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0543-2 · Cited by 25
“However, such adaptations also aVect malignant progression, metastasis and therapeutic resistance ( Liao et al. 2007; Hiraga et al. 2007; Stoeltzing et al. 2004).”
Polyphyllin D Exerts Potent Anti-tumour Effects on Lewis Cancer Cells under Hypoxic Conditions
Ma, D.-D., Lu, H.-X., Xu, L.-S., & Xiao, W. L. (2009) · Journal of International Medical Research · doi:10.1177/147323000903700305 · Cited by 25
Accelerating the discovery of anticancer peptides targeting lung and breast cancers with the Wasserstein autoencoder model and PSO algorithm
Yang, L., Yang, G., Bing, Z., Tian, Y., Huang, L., Niu, Y., & Yang, L. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac320 · Cited by 24
Hypoxia inducible factor signaling in breast tumors controls spontaneous tumor dissemination in a site-specific manner
Todd, V. M., Vecchi, L. A., Clements, M. E., Snow, K. P., Ontko, C. D., Himmel, L. E., Pinelli, C. J., Rafat, M., & Johnson, R. W. (2021) · Communications Biology · doi:10.1038/s42003-021-02648-3 · Cited by 26
Self-citation
Genome-independent hypoxic repression of estrogen receptor alpha in breast cancer cells
Padró, M., Louie, R. J., Lananna, B. V., Krieg, A. J., Timmerman, L., & Chan, D. A. (2017) · BMC Cancer · doi:10.1186/s12885-017-3140-9 · Cited by 25
Ethanol extract of baked Gardeniae Fructus exhibits in vitro and in vivo anti-metastatic and anti-angiogenic activities in malignant cancer cells: Role of suppression of the NF-κB and HIF-1α pathways
Im, M., Kim, A., & Yeul, J. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3742 · Cited by 23
Selective ETAR antagonist atrasentan inhibits hypoxia-induced breast cancer cell invasion
Smollich, M., Götte, M., Kersting, C., Fischgräbe, J., Kiesel, L., & Wülfing, P. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9589-5 · Cited by 23
“to chemotherapy [13, 14], and the transcriptional activity of HIF-1a is an important positive regulator of tumour progression and metastatic potential [15].”
Suppression of Glioma Progression by Egln3
Sciorra, V. A., Sanchez, M. A., Kunibe, A., & Wurmser, A. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040053 · Cited by 23
Anti-cancer efficacy including Rb-deficient tumors and VHL-independent HIF1α proteasomal destabilization by dual targeting of CDK1 or CDK4/6 and HSP90
Zhao, S., Zhou, L., Dicker, D. T., Lev, A., Zhang, S., Ross, E. A., & El‐Deiry, W. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-00150-8 · Cited by 22
Generation, secretion and degradation of cancer immunotherapy target PD-L1
Shen, D., Bi, Y., Pang, J., Zhao, L., Zhao, L., Gao, Y., Wang, B., Liu, H., Liu, Y., Wang, N., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04431-x · Cited by 24
Novel potent HIF-1 inhibitors for the prevention of tumor metastasis: discovery and optimization of 3-aryl-5-indazole-1,2,4-oxadiazole derivatives
Sheng, R., Li, S., Lin, G., Shangguan, S., Gu, Y., Qiu, N., Cao, J., He, Q., Yang, B., & Hu, Y. (2015) · RSC Advances · doi:10.1039/c5ra15191k · Cited by 22
Obligate anaerobic Salmonella typhimurium strain YB1 treatment on xenograft tumor in immunocompetent mouse model
Yu, B., Shi, L., ZHANG, B.-Z., ZHANG, K., Peng, X., Niu, H., & Qu, J. (2015) · Oncology Letters · doi:10.3892/ol.2015.3302 · Cited by 21
15‐LOX‐1 suppression of hypoxia‐induced metastatic phenotype and HIF‐1α expression in human colon cancer cells
Wu, Y., Mao, F., Zuo, X., Moussalli, M. J., Elias, E., Xu, W., & Shureiqi, I. (2014) · Cancer Medicine · doi:10.1002/cam4.222 · Cited by 21
“HIF-1a inhibition or targeted genetic deletion suppresses metastasis in various preclinical models [32, 33]; therefore, molecular targeting of HIF-1a has been pursued [34].”
Background
Genotype × diet interactions in mice predisposed to mammary cancer. I. Body weight and fat
Gordon, R. R., Hunter, K. W., Sørensen, P., & Pomp, D. (2008) · Mammalian Genome · doi:10.1007/s00335-008-9095-z · Cited by 20
“High-fat diet has been studied as a risk factor for mammary tumors in mice (e.g., Cleary et al. 2004; Tannenbaum 1942), and several genetic modifiers of mammary tumor development have been identified in various transgenic mouse models (Connelly et al. 2007; Le Voyer et al. 2000, 2001; Liao et al. 2007; Rajkumar et al.…”
Background
Scriptaid overcomes hypoxia-induced cisplatin resistance in both wild-type and mutant p53 lung cancer cells
Pradhan, S. N., Mahajan, D., Kaur, P., Pandey, N., Sharma, C., & Srivastava, T. (2016) · Oncotarget · doi:10.18632/oncotarget.12378 · Cited by 21
Analysis of the effects of exposure to acute hypoxia on oxidative lesions and tumour progression in a transgenic mouse breast cancer model
Kalliomäki, T., McCallum, G. P., Lunt, S. J., Wells, P. G., & Hill, R. P. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-151 · Cited by 20
“Hypoxia has been reported to enhance metastatic tumour progression and to be associated with oxidative stress, genomic instability and TAMs [21, 36-38 ].”
Background
Immunohistochemical profile of HIF-1α, VEGF-A, VEGFR2 and MMP9 proteins in tegumentary leishmaniasis
Fraga, C. A. D. C., de Oliveira, M. V. M., Alves, L. R., Viana, A. G., de Sousa, A. A., de Carvalho, S. F. G., de Paula, A. M. B., Botelho, A. C. D. C., & Guimarães, A. L. S. (2012) · Anais Brasileiros de Dermatologia · doi:10.1590/s0365-05962012000500006 · Cited by 20
Hypoxia-inducible factor-1α enhances the malignant phenotype of multicellular spheroid HeLa cells in vitro
Tian, X., Wang, W., Zhang, Q., Zhao, L., Wei, J., Xing, H., Song, Y., Wang, S., Ma, D., Li, M., et al. (2010) · Oncology Letters · doi:10.3892/ol_00000159 · Cited by 20
The potential role of Brachyury in inducing epithelial-to-mesenchymal transition (EMT) and HIF-1α expression in breast cancer cells
Shao, C., Zhang, J., Fu, J., & Ling, F. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.09.076 · Cited by 19
RNA interference of hypoxia-inducible factor-1 alpha improves the effects of transcatheter arterial embolization in rat liver tumors
Chen, C., Wang, J., Liu, R., & Qian, S. (2012) · Tumor Biology · doi:10.1007/s13277-012-0349-8 · Cited by 19
Differential HIF-1α and HIF-2α Expression in Mammary Epithelial Cells during Fat Pad Invasion, Lactation, and Involution
Påhlman, S., Lund, L. R., & Jögi, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125771 · Cited by 19
Afrostyrax lepidophyllus extracts exhibit in vitro free radical scavenging, antioxidant potential and protective properties against liver enzymes ion mediated oxidative damage
Moukette, B. M., Pieme, C. A., Nya, P. C. B., Moor, V. J. A., Berinyuy, E. B., & Ngogang, J. Y. (2015) · BMC Research Notes · doi:10.1186/s13104-015-1304-8 · Cited by 19
Dose-dependent modulation of HIF-1α/sima controls the rate of cell migration and invasion in Drosophila ovary border cells
Doronkin, S., Djagaeva, I., Nagle, M. E., Reiter, L. T., & Seagroves, T. N. (2009) · Oncogene · doi:10.1038/onc.2009.407 · Cited by 19
Self-citation
Selenium-containing compounds, selenium nanoparticles and selenoproteins in the prevention and treatment of lung cancer
Varlamova, E. G. (2025) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2025.127620 · Cited by 20
Efficient inhibition of uveal melanoma via ternary siRNA complexes
Xie, L., Yang, Y., & Shen, J. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118894 · Cited by 19
“Downregulation of hypoxia-inducible factor (HIF) has been shown to decrease metastatic potential of various tumor cells such as breast cancer, lung cancer, and melanoma (Hanna et al., 2013; Hiraga et al., 2007; Liao et al., 2007; Wong et al., 2011; Zhang et al., 2012).”
Background
A hypoxic signature marks tumors formed by disseminated tumor cells in the BALB-neuT mammary cancer model
Msaki, A., Pastò, A., Curtarello, M., Arigoni, M., Barutello, G., Calogero, R., Macagno, M., Cavallo, F., Amadori, A., & Indraccolo, S. (2016) · Oncotarget · doi:10.18632/oncotarget.8859 · Cited by 18
“Hypoxia not only promotes cancer dissemination and stemness, but it has also been described to promote metastasis from bone to lung [37, 41, 42], raising the hypothesis that lung metastasis could stem from BM-derived DTC.”
Potent antitumor activity of Oct4 and hypoxia dual-regulated oncolytic adenovirus against bladder cancer
Lu, C.-S., Hsieh, J.-L., Lin, C.-Y., Tsai, H.-W., Su, B.-H., Shieh, G.-S., Su, Y.-C., Lee, C.-H., Chang, M.-Y., Wu, C., et al. (2015) · Gene Therapy · doi:10.1038/gt.2014.122 · Cited by 17
DIMming Ovarian Cancer Growth
Kandala, P. K., & Srivastava, S. (2012) · Current Drug Targets · doi:10.2174/138945012804545650 · Cited by 16
“It has been identified that angiogenic factors, such as vascular endothelial growth factors (VEGF) and HIF-1 are important regulators of tumor growth, both at the primary tumor site and distant metastasis [58, 59].”
Background
VHL Deletion Impairs Mammary Alveologenesis but Is Not Sufficient for Mammary Tumorigenesis
Seagroves, T. N., Peacock, D. L., Liao, D., Schwab, L. P., Krueger, R. L., Handorf, C. R., Haase, V. H., & Johnson, R. S. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090310 · Cited by 15
Self-citation
Transgenic Models to Understand Hypoxia‐Inducible Factor Function
Doedens, A. L., & Johnson, R. S. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)35005-2 · Cited by 16
Self-citation
Progressive increase of glucose transporter-3 (GLUT-3) expression in estrogen-induced breast carcinogenesis
Koçdor, M. A., Koçdor, H., Pereira, J. S., Vanegas, J. E., Russo, I. H., & Russo, J. (2012) · Clinical & Translational Oncology · doi:10.1007/s12094-012-0882-3 · Cited by 16
Sirtuin 6 and metabolic genes interplay in Warburg effect in cancers
Al‐Azzam, N. Z. (2020) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.19-110 · Cited by 16
Hypoxia response pathway in border cell migration
Djagaeva, I., & Doronkin, S. (2010) · Cell Adhesion & Migration · doi:10.4161/cam.4.3.11790 · Cited by 16
Hypoxia inducible factor 1α expression and effects of its inhibitors in canine lymphoma
Kambayashi, S., Igase, M., Kobayashi, K., KIMURA, A., MIYAMA, T. S., Baba, K., Noguchi, S., Mizuno, T., & Okuda, M. (2015) · Journal of Veterinary Medical Science · doi:10.1292/jvms.15-0258 · Cited by 15
The “Sharp”blade against HIF-mediated metastasis
Amelio, I., & Melino, G. (2012) · Cell Cycle · doi:10.4161/cc.22820 · Cited by 15
Second-generation HIF-activated oncolytic adenoviruses with improved replication, oncolytic, and antitumor efficacy
Cherry, T., Longo, S. L., Tovar-Spinoza, Z. S., & Post, D. E. (2010) · Gene Therapy · doi:10.1038/gt.2010.100 · Cited by 15
Ex vivo identification of circulating tumor cells in peripheral blood by fluorometric “turn on” aptamer nanoparticles
Xia, W., Shangguan, X., Li, M., Wang, Y., Xi, D., Sun, W. C., Fan, J., Shao, K., & Peng, X. (2020) · Chemical Science · doi:10.1039/d0sc05112h · Cited by 15
Association between genetic polymorphisms involved in the hypoxia-inducible factor pathway and lung cancer risk: a case-control study in Japan
Yamamoto, Y., Kiyohara, C., Ogata-Suetsugu, S., Hamada, N., & Nakanishi, Y. (2016) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.12640 · Cited by 15
Fungus-derived hydroxyl radicals kill hepatic cells by enhancing nuclear transglutaminase
Shrestha, R., Shrestha, R., Qin, X., Kuo, T., Oshima, Y., Iwatani, S., Teraoka, R., Fujii, K., Hara, M., Li, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-04630-8 · Cited by 15
Identification of a Novel Biomarker Signature Associated with Risk for Bone Metastasis in Patients with Renal Cell Carcinoma
Paule, B., Deslandes, E., Mouel, S. E. L., Bastien, L., Podgorniak, M.-P., Allory, Y., TAILLE, A. D. L., Ménashi, S., Calvo, F. M., & Mourah, S. (2010) · The International Journal of Biological Markers · doi:10.1177/172460081002500209 · Cited by 15
Conducive target range of breast cancer: Hypoxic tumor microenvironment
Cheng, W., Xiao, X., Liao, Y., Cao, Q., Wang, C., Li, X., & Jia, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.978276 · Cited by 14
Associations between HIFs and tumor immune checkpoints: mechanism and therapy
Liu, J., Jiang, Y., Chen, L., Qian, Z., & Zhang, Y. (2024) · Discover Oncology · doi:10.1007/s12672-023-00836-7 · Cited by 13
Role of anti-angiogenic factors in the pathogenesis of breast cancer: A review of therapeutic potential
Ruan, L., Zhang, S., Chen, X., Liang, W., & Xie, Q. (2022) · Pathology - Research and Practice · doi:10.1016/j.prp.2022.153956 · Cited by 13
Iron Deficiency Increases Phosphorylation of SP1 to Upregulate SPNS2 Expression in Hepatocellular Carcinoma
Wang, D., Li, M., Shen, H., Yang, J., Gao, Z., & Tang, Y. (2022) · Biological Trace Element Research · doi:10.1007/s12011-022-03296-2 · Cited by 13
Hypoxia-Inducible Expression of Annexin A6 Enhances the Resistance of Triple-Negative Breast Cancer Cells to EGFR and AR Antagonists
Williams, S. D., Smith, T. M., Stewart, L. V., & Sakwe, A. M. (2022) · Cells · doi:10.3390/cells11193007 · Cited by 13
“of breast cancer cells to axillary lymph nodes [10], lungs [11,12] and bone [13,14].”
Background
Does Loss of CD151 Expression Promote the Metastasis of Hypoxic Colon Cancer Cells?
Semenza, G. L. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2417 · Cited by 13
Cellular stress stimulates nuclear localization signal (NLS) independent nuclear transport of MRJ
Andrews, J., Sykora, L. J., Letostak, T. B., Menezes, M. E., Mitra, A., Barik, S., Shevde, L. A., & Samant, R. S. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.03.024 · Cited by 13
Ropivacaine Inhibits Lung Cancer Cell Malignancy Through Downregulation of Cellular Signaling Including HIF-1α In Vitro
Shen, J., Han, L., Xue, Y., Li, C., Jia, H., & Zhu, K. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.806954 · Cited by 12
Apicidin upregulates PHD2 prolyl hydroxylase gene expression in cervical cancer cells
Durczak, M., & Jagodziński, P. P. (2010) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328339848b · Cited by 12
Association of Romo1 Gene Genetic Polymorphisms with Risk of Gastric Cancer in Northwestern Chinese Population
Wu, H., Gu, Y., Li, W., Guo, T., Zhao, Y., Su, G., Li, J., & Xie, X. (2014) · Pathology & Oncology Research · doi:10.1007/s12253-014-9858-7 · Cited by 12
Mint3 in bone marrow-derived cells promotes lung metastasis in breast cancer model mice
Hara, T., Murakami, Y., Seiki, M., & Sakamoto, T. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.06.102 · Cited by 12
Consequences of Extracellular Matrix Remodeling in Headway and Metastasis of Cancer along with Novel Immunotherapies: A Great Promise for Future Endeavor
Ray, S. K., & Mukherjee, S. (2021) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520621666210712090017 · Cited by 13
Identification of a Survival-independent Metastasis-enhancing Role of Hypoxia-inducible Factor-1α with a Hypoxia-tolerant Tumor Cell Line
Schelter, F., Gerg, M., Halbgewachs, B., Schaten, S., Görlach, A., Schrötzlmair, F., & Krüger, A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.140608 · Cited by 12
Discovery of potent hypoxia-inducible factor-1α (HIF-1α) degraders by proteolysis targeting chimera (PROTAC)
Li, Y., Zhu, R., He, X., Song, Y., Fan, T., Ma, J., Xiang, G., & Xiang, G. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107943 · Cited by 11
Dormancy in the Tumor Microenvironment
Omokehinde, T., & Johnson, R. W. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-73119-9_2 · Cited by 11
Self-citation
Development of Lymphoproliferative Diseases by Hypoxia Inducible Factor-1alpha Is Associated with Prolonged Lymphocyte Survival
Sueoka, E., Sueoka‐Aragane, N., Sato, A., Ide, M., Nakamura, H., Sotomaru, Y., Taya, C., Yonekawa, H., Kitagawa, T., Kubota, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057833 · Cited by 11
Inhibition of protein synthesis by imexon reduces HIF-1α expression in normoxic and hypoxic pancreatic cancer cells
Samulitis, B. K., Landowski, T. H., & Dorr, R. T. (2008) · Investigational New Drugs · doi:10.1007/s10637-008-9149-9 · Cited by 11
“These hypoxic cells are also capable of developing new vasculature which promotes both local tumor growth and distant metastatic spread [ 25 ].”
Development of small molecule inhibitors of hypoxia-inducible factors for cancer therapy
Semenza, G. L. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100075 · Cited by 10
Expression of EMMPRIN Modulates Mediators of Tumor Invasion in Oral Squamous Cell Carcinoma
Siu, A., Chang, J. W., Lee, C., Lee, S., Lee, C. S., & Ramos, D. M. (2013) · Journal of the California Dental Association · doi:10.1080/19424396.2013.12222372 · Cited by 9
Fluorescence-Activated Cell Sorting of Murine Mammary Cancer Stem-Like Cell Subpopulations with HIF Activity
Brooks, D. L. P., & Seagroves, T. N. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7665-2_22 · Cited by 9
Self-citation
Molecular insights of newly identified potential peptide inhibitors of hypoxia inducible factor 1α causing breast cancer
Manimaran, D., Ghanendra, S., Sridhar, M., Kaliaperumal, J., Muniaraj, S., Mohankumar, T., Vijayakumar, R., Krishnan, M., Balakrishnan, R., & Elangovan, N. (2018) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2018.09.072 · Cited by 9
HACE1 blocks HIF1α accumulation under hypoxia in a RAC1 dependent manner
Turgu, B., Zhang, F., El-Naggar, A. M., Negri, G. L., Kögler, M., Tortola, L., Johnson, F. D., Ng, T., Li, A., Yapp, D. T. T., et al. (2021) · Oncogene · doi:10.1038/s41388-021-01680-1 · Cited by 9
Disorders of Blood Cell Production in Clinical Oncology
Glaspy, J. A. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00034-5 · Cited by 9
Role of GPX3+ astrocytes in breast cancer brain metastasis activated by circulating tumor cell exosomes
Huang, G., Xu, G., Cao, Q., Li, S., Li, Z., Zhang, X., & Li, X. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-00833-9 · Cited by 11
Nuclear-translocated endostatin downregulates hypoxia inducible factor-1α activation through interfering with Zn(II) homeostasis
Guo, L., Chen, Y., He, T., Qi, F., LIU, G., Fu, Y., RAO, C., Wang, J., & Luo, Y. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3223 · Cited by 8
RNAi Knockdown of Hypoxia-Inducible Factor-1α Decreased the Proliferation, Migration, and Invasion of Hypoxic Hepatocellular Carcinoma Cells
Chen, C., Liu, R., Wang, J., Yan, Z., Qian, S., & Zhang, W. J. (2014) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-0390-x · Cited by 8
“Most recently, HIF-1a was shown to be a significant positive regulator of tumor progression and metastasis in a transgenic mouse model of cancer [32].”
Background
MARVELD1 interacting with catalase regulates reactive oxygen species metabolism and mediates the sensitivity to chemotherapeutic drugs in epithelial tumors of the reproductive system
Zhang, C., Han, F., Shi, M., Sun, H., Li, Y., Ci, Y., Yao, Y., Dou, P., Akhtar, M. L., Nie, H., et al. (2019) · Molecular Carcinogenesis · doi:10.1002/mc.23024 · Cited by 8
The radiosensitising effect of gemcitabine and its main metabolite dFdU under low oxygen conditions is in vitro not dependent on functional HIF-1 protein
Wouters, A., Pauwels, B., Burrows, N., Baay, M. F. D., Deschoolmeester, V., Vu, T. N., Laukens, K., Meijnders, P., Gestel, D. V., Williams, K. J., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-594 · Cited by 7
Manganese Porphyrin and Radiotherapy Improves Local Tumor Response and Overall Survival in Orthotopic Murine Mammary Carcinoma Models
Boss, M., Oberley‐Deegan, R. E., Batinic̈‐Haberle, I., Talmon, G. A., Somarelli, J. A., Xu, S., Kosmacek, E. A., Griess, B., Mir, S. U. R., Shrishrimal, S., et al. (2020) · Radiation Research · doi:10.1667/rade-20-00109.1 · Cited by 7
Localization of Fusobacterium nucleatum in oral squamous cell carcinoma and its possible directly interacting protein molecules: A case series.
He, X., Ma, X., Meng, Z., Han, Z., & Chen, W. (2023) · PubMed · doi:10.14670/hh-18-560 · Cited by 7
Design, optimization, characterization, and in vitro evaluation of metformin-loaded liposomes for triple negative breast cancer treatment
Vozgirdaite, D., Hervé-Aubert, K., Uzbekov, R. E., Chourpa, I., & Allard-Vannier, É. (2024) · Journal of Liposome Research · doi:10.1080/08982104.2024.2321528 · Cited by 7
Tumour Hypoxia and the Hypoxia-Inducible Transcription Factors: Key Players in Cancer Progression and Metastasis
Jögi, A. (2015) · Springer eBooks · doi:10.1007/978-3-7091-1824-5_4 · Cited by 7
Directed Hydrogenation of Acyclic Homoallylic Alcohols: Enantioselective Syntheses of (+)- and (−)-Laurenditerpenol
Chittiboyina, A. G., Peddikotla, P., Avery, M. A., & Khan, I. A. (2013) · The Journal of Organic Chemistry · doi:10.1021/jo401461x · Cited by 7
Role of Cytokines in Tumor Immunity and Immune Tolerance to Cancer
Murugaiyan, G. (2014) · Springer eBooks · doi:10.1007/978-3-662-44006-3_7 · Cited by 6
The Cellular Microenvironment and Metastases
Rankin, E. B., Erler, J. T., & Giaccia, A. J. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00003-5 · Cited by 6
Unveiling the anticancer potential of milk thistle in hepatocellular carcinoma: A network pharmacology perspective
Mishra, T., & Kaundal, R. K. (2025) · PharmaNutrition · doi:10.1016/j.phanu.2025.100458 · Cited by 5
Development of a Novel Anti-HIF-1α Screening System Coupled with Biochemical and Biological Validation for Rapidly Selecting Potent Anti-Cancer Compounds
Lu, Y. W., Madu, C. O., Masters, J. S., Lu, A., & Li, L. (2014) · Journal of Cancer · doi:10.7150/jca.9205 · Cited by 5
Green Synthesis of Oxoquinoline-1(2H)-Carboxamide as Antiproliferative and Antioxidant Agents: An Experimental and In-Silico Approach to High Altitude Related Disorders
Ali, A., Ali, A., Warsi, M. H., Rahman, M. A., Ahsan, M. J., & Azam, F. (2022) · Molecules · doi:10.3390/molecules27010309 · Cited by 5
Polymorphisms in HIFs and breast cancer sutarsceptibility in Chinese women: a case–control study
Shan, C., Zheng, Y., Wang, M., Lin, S., Tian, T., Deng, Y., Xu, P., Hao, Q., Wu, Y., Yang, T., et al. (2018) · Bioscience Reports · doi:10.1042/bsr20180950 · Cited by 5
CAR-T cell therapy for solid tumors: HIF-1α as a potential enhancement strategy
Li, H., Xiong, J., Wang, C. H., Hu, L. B., Wang, Y. B., Ping, Q. R., Yang, M., Tan, J., Li, T., & Yang, Y. (2025) · Autoimmunity · doi:10.1080/08916934.2025.2579069 · Cited by 7
Role of Cytokines in Tumor Immunity and Immune Tolerance to Cancer
Garo, L. P., & Murugaiyan, G. (2020) · Springer eBooks · doi:10.1007/978-3-030-30845-2_13 · Cited by 5
Loss of sphingosine kinase 1 increases lung metastases in the MMTV-PyMT mouse model of breast cancer
Velazquez, F. N., Zhang, L., Viscardi, V., Trocchia, C., Hannun, Y. A., Obeid, L. M., & Snider, A. J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252311 · Cited by 4
“Deletion of HIF1α in MMTV-PyMT mice caused a significant reduction in lung metastases, highlighting the role of this transcription factor in the progression of the disease [57].”
Background
Cellular Microenvironment and Metastases
Rankin, E. B., & Giaccia, A. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00003-7 · Cited by 4
Hypoxia-Inducible Factors-Based Single Nucleotide Polymorphism in Breast Cancer with More Cancer Susceptibility
Ray, S. K., & Mukherjee, S. (2022) · Current Molecular Medicine · doi:10.2174/1566524022666220513124853 · Cited by 5
ΔNp73 enhances HIF-1α protein stability through repression of the ECV complex
Stantic, M., Wolfsberger, J., Sakil, H. A. M., & Wilhelm, M. (2018) · Oncogene · doi:10.1038/s41388-018-0195-2 · Cited by 4
Metastasis‐associated gene, mag‐1 improves tumour microenvironmental adaptation and potentiates tumour metastasis
Wang, Y., Jia, H., Lin, H., Tan, X., Du, Z., Chen, H., Xu, Y., Han, X., Zhang, J., Zhao, S., et al. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01633.x · Cited by 5
The Complexity of the HIF-1-Dependent Hypoxic Response in Breast Cancer Presents Multiple Avenues for Therapeutic Intervention
Seagroves, T. N. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0131-6_16 · Cited by 3
Self-citation
Hypoxia-induced nitric oxide release by luminal cells stimulates proliferation and uPA secretion of myoepithelial cells in a bicellular murine mammary tumor
Krasnapolski, M. A., Lodillinsky, C., Joffé, E. B. D. K., & Eiján, A. M. (2015) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-015-1934-1 · Cited by 3
“It was described that migration of tumor cells during hematogenous metastasis is related to a HIF-driven response (Liao et al. 2007).”
Hypoxia and Breast Cancer Metastasis
Schito, L., & Semenza, G. L. (2013) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4614-9167-5_1 · Cited by 5
“…the role of hypoxia and HIF-1α overexpression with increased angiogenesis and hematogenous dissemination (Erler et al. 2006a; Chan and Giaccia 2007; Liao et al. 2007; Rundqvist and Johnson 2010; Cooke et al. 2012) contrasts with the lack of studies addressing the role of HIF-1α in…”
BackgroundInfluential
P2RX7 inhibition reduces breast cancer induced osteolytic lesions - implications for bone metastasisPreprint
Shah, K. M., Tattersall, L., Hussain, A., Macfarlane, S. C., Williamson, A., Acosta‐Martin, A. E., Erler, J. T., Ottewell, P. D., & Gartland, A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.31.474644 · Cited by 3
Comprehensive Evaluation of Bacillus Calmette–Guérin therapy in Non-muscle invasive bladder cancer Egyptian patients: a retrospective cohort study
Karkeet, R. M., Sayed-Ahmed, M. M., Ghaly, S., Farouk, M., Yasser, N., Hany, N., Atta, M., Amer, A. M., & Abdelbary, A. (2026) · Journal of the Egyptian National Cancer Institute · doi:10.1186/s43046-026-00340-3 · Cited by 2
Engineered nanoparticle systems targeting tumor angiogenesis: bridging molecular mechanisms and therapeutic innovations
Kanthireegala, S. K., Lekkala, V. V. V., Lebaka, V. R., Reddy, M. C., Lomada, D., & Mandal, T. K. (2026) · Biomaterials Science · doi:10.1039/d5bm01787d · Cited by 3
Role of transcription factors in metastasis of breast cancer
Marada, S., Madu, C. O., & Lu, Y. W. (2024) · Exploration of Medicine · doi:10.37349/emed.2024.00267 · Cited by 3
Antioxidants and Their Effect on Stress-Induced Pathology in the Inner Ear
Shirwany, N. A., & Seidman, M. D. (2015) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-319-13473-4_4 · Cited by 2
Progression of Lung Cancer: Role of Hypoxia and the Metabolic Tumor Microenvironment
Leithner, K., & Olschewski, H. (2017) · Springer eBooks · doi:10.1007/978-3-319-53659-0_18 · Cited by 2
Chromatin Immunoprecipitation of HIF-α in Breast Tumor Cells Using Wild Type and Loss of Function Models
Brooks, D. L. P., & Seagroves, T. N. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7665-2_7 · Cited by 2
Self-citation
A pre-screening strategy to assess resected tumor margins by imaging cytoplasmic viscosity and hypoxia
Huang, H., Lin, Y., Ma, W., Liu, J., Han, J., Hu, X., Tang, M., Yan, S., Abudupataer, M., Zhang, C., et al. (2021) · eLife · doi:10.7554/elife.70471 · Cited by 2
[Advances of HIF-1alpha and Its Role in Lung Cancer.].
Lv, Y., & Zhang, P. (2009) · PubMed · doi:10.3779/j.issn.1009-3419.2009.02.13 · Cited by 2
Adenylate kinase-4 modulates oxidative stress and stabilizes HIF-1α to drive lung cancer metastasisPreprint
Jan, Y., Lai, T., Yang, C., Lin, Y., Huang, M., & Hsiao, M. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/196857 · Cited by 2
Impact of Tumor Hypoxia, Src, and Met Signaling in the Dissemination of Tumor Cells
Dai, Y., Shi, W.-Y., Molnar, N., & Siemann, D. (2011) · Springer eBooks · doi:10.1007/978-94-007-2558-4_7 · Cited by 2

Authors: Liao, D., Corle, C., Seagroves, T. N., & Johnson, R. S.
Affiliations: University of California San Diego (US)
1Division of Biological Sciences, Molecular Biology Section, and
ORCID: Liao, Debbie
Seagroves, Tiffany N.
Johnson, Randall S.
Venue: Cancer Research
Publisher: American Association for Cancer Research (AACR)
Published: 2007-01-15
Volume: 67
Issue: 2
Pages: 563-572
ISSN: 0008-5472 (ISSN-L)
1538-7445
DOI: 10.1158/0008-5472.can-06-2701
OpenAlex: W2167510293
Cited by: 339
References: 38
Citations by year: 2026: 4 · 2025: 6 · 2024: 5 · 2023: 9 · 2022: 17 · 2021: 20 · 2020: 13 · 2019: 14 · 2018: 14 · 2017: 14 · 2016: 17 · 2015: 26 · 2014: 21 · 2013: 25 · 2012: 29
FWCI: 10.27
Type: journal article
Language: en
Open access: closed
Locations: Cancer Research (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (R01CA082515, CA 082515)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
Keywords: hypoxia-inducible factor-1α, metastasis, breast cancer, tumor initiation, tumor progression, mammary epithelium, conditional gene deletion, transgenic mouse model, tumor hypoxia, tumor cell proliferation, tumor vascularization, lung metastasis
MeSH terms: Animals, Female, Hyperplasia, Lung Neoplasms, Male, Mammary Neoplasms, Experimental, Mice, Transgenic, Neoplasm Metastasis, Transcription, Genetic, Mammary Neoplasms, Animal, Mice, Knockout, Disease Progression, Cell Growth Processes, Mice, Hypoxia-Inducible Factor 1, alpha Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Hypoxia-Inducible Factor-1α Is a Key Regulator of Metastasis in a Transgenic Model of Cancer Initiation and Progression

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks